![Andrew King](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew King
Keine laufenden Positionen mehr
Karriereverlauf von Andrew King
Ehemalige bekannte Positionen von Andrew King
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHINOOK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.06.2021 | 09.08.2023 |
Corporate Officer/Principal | 01.05.2019 | 07.06.2021 | |
ARDELYX, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Andrew King
Murdoch University | Undergraduate Degree |
Michigan State University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Australien | 2 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ARDELYX, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Chinook Therapeutics, Inc.
![]() Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Andrew King
- Erfahrung